CoChat

NLRC5/CITA: A Key Player in Cancer Immune Surveillance

Open access
Yoshihama, Sayuri, Vijayan, Saptha, Sidiq, Tabasum, Kobayashi, Koichi S. · 2017 · Trends in Cancer
Cited by 94

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Cancer cells need to escape immune surveillance for successful tumor growth. Loss of MHC class I has been described as a major immune evasion strategy in many cancers. MHC class I transactivator (CITA), NLRC5, has found to be a key transcription coactivator of MHC class I genes. Recent genetic studies revealed that NLRC5 is a major target for cancer immune evasion mechanism. The reduced expression or activity of NLRC5 caused by promoter methylation, copy number loss, or somatic mutations is associated with defective MHC class I expression, impaired cytotoxic T cell activation and poor patient prognosis. Here we review the role of NLRC5 in cancer immune evasion and the future prospects for cancer research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.trecan.2016.12.003

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 17 references

Cited by

See all 94

Metadata

Authors
Yoshihama, S., Vijayan, S., Sidiq, T., & Kobayashi, K. S.
Venue
Trends in Cancer
Publisher
Elsevier BV
Published
2017-01
Volume
3
Issue
1
Pages
28-38
ISSN
  • 2405-8025 (ISSN-L)
  • 2405-8033
OpenAlex
W2569601970
Cited by
94
References
17
FWCI
0.80
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NLRC5/CITA: A Key Player in Cancer Immune Surveillance. https://app.cochat.ai/papers/10.1016/j.trecan.2016.12.003
The paper
Yoshihama, S., Vijayan, S., Sidiq, T., & Kobayashi, K. S. (2017). NLRC5/CITA: A Key Player in Cancer Immune Surveillance. Trends in Cancer. https://doi.org/10.1016/j.trecan.2016.12.003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.